SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-028401
Filing Date
2021-04-26
Accepted
2021-04-26 19:02:06
Documents
1
Period of Report
2021-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7365
  Complete submission text file 0001209191-21-028401.txt   10041
Mailing Address C/O NORWEST VENTURE PARTNERS 525 UNIVERSITY AVENUE, SUITE 800 PALO ALTO CA 94301
Business Address
HAQUE PROMOD (Reporting) CIK: 0001089744 (see all company filings)

State of Incorp.: CA
Type: 4 | Act: 34 | File No.: 001-40353 | Film No.: 21855445

Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL NEUROPHARMA INC (Issuer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 525 UNIVERSITY AVENUE SUITE 800 PALO ALTO CA 94301
Business Address
Crowe Jeffrey (Reporting) CIK: 0001535261 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40353 | Film No.: 21855446

Mailing Address 525 UNIVERSITY AVENUE, SUITE 800 PALO ALTO CA 94025
Business Address
Kossow Jon Erik (Reporting) CIK: 0001726084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40353 | Film No.: 21855444

Mailing Address 525 UNIVERSITY AVENUE SUITE 800 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 800 PALO ALTO CA 94301 650-321-8000
Norwest Venture Partners XIV, LP (Reporting) CIK: 0001842721 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40353 | Film No.: 21855447